1. Home
  2. BFS vs AVXL Comparison

BFS vs AVXL Comparison

Compare BFS & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFS
  • AVXL
  • Stock Information
  • Founded
  • BFS 1993
  • AVXL 2004
  • Country
  • BFS United States
  • AVXL United States
  • Employees
  • BFS N/A
  • AVXL N/A
  • Industry
  • BFS Real Estate Investment Trusts
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BFS Real Estate
  • AVXL Health Care
  • Exchange
  • BFS Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • BFS 830.6M
  • AVXL 794.0M
  • IPO Year
  • BFS 1993
  • AVXL N/A
  • Fundamental
  • Price
  • BFS $34.82
  • AVXL $9.32
  • Analyst Decision
  • BFS Strong Buy
  • AVXL Strong Buy
  • Analyst Count
  • BFS 1
  • AVXL 2
  • Target Price
  • BFS $45.50
  • AVXL $44.00
  • AVG Volume (30 Days)
  • BFS 66.3K
  • AVXL 927.5K
  • Earning Date
  • BFS 07-31-2025
  • AVXL 08-05-2025
  • Dividend Yield
  • BFS 6.77%
  • AVXL N/A
  • EPS Growth
  • BFS N/A
  • AVXL N/A
  • EPS
  • BFS 1.47
  • AVXL N/A
  • Revenue
  • BFS $274,011,000.00
  • AVXL N/A
  • Revenue This Year
  • BFS $7.78
  • AVXL N/A
  • Revenue Next Year
  • BFS $6.78
  • AVXL N/A
  • P/E Ratio
  • BFS $23.22
  • AVXL N/A
  • Revenue Growth
  • BFS 5.04
  • AVXL N/A
  • 52 Week Low
  • BFS $31.25
  • AVXL $4.00
  • 52 Week High
  • BFS $42.39
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • BFS 47.76
  • AVXL 60.62
  • Support Level
  • BFS $33.50
  • AVXL $9.09
  • Resistance Level
  • BFS $34.69
  • AVXL $9.78
  • Average True Range (ATR)
  • BFS 0.74
  • AVXL 0.41
  • MACD
  • BFS -0.11
  • AVXL 0.09
  • Stochastic Oscillator
  • BFS 27.04
  • AVXL 71.58

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: